Zalcberg JR - Search Results

1

Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780.

Hu XF, Veroni M, De Luise M, Wakeling A, Sutherland R, Watts CK, Zalcberg JR. Hu XF, et al. Among authors: zalcberg jr. Int J Cancer. 1993 Nov 11;55(5):873-6. doi: 10.1002/ijc.2910550529. Int J Cancer. 1993. PMID: 8244585

2

Interaction of epirubicin with other cytotoxics and anti-emetic drugs.

Zhang W, Zalcberg JR, Cosolo W. Zhang W, et al. Among authors: zalcberg jr. Anticancer Drugs. 1992 Dec;3(6):593-7. doi: 10.1097/00001813-199212000-00006. Anticancer Drugs. 1992. PMID: 1288730

3

Recent advances in the treatment of colorectal cancer.

Wirth A, Green M, Penfold C, Hurley R, Matthews J, Burns I, Zalcberg J. Wirth A, et al. Aust N Z J Med. 1992 Feb;22(1):61-8. doi: 10.1111/j.1445-5994.1992.tb01713.x. Aust N Z J Med. 1992. PMID: 1580867 Review. No abstract available.

4

Familial occurrence of multiple nonmelanoma skin cancer.

Czarnecki D, Zalcberg J, Meehan C, O'Brien T, Leahy S, Bankier A, Nash CG. Czarnecki D, et al. Cancer Genet Cytogenet. 1992 Jul 1;61(1):1-5. doi: 10.1016/0165-4608(92)90361-b. Cancer Genet Cytogenet. 1992. PMID: 1638472

5

Circumvention of doxorubicin resistance in multi-drug resistant human leukaemia and lung cancer cells by the pure antioestrogen ICI 164384.

Hu XF, Nadalin G, De Luise M, Martin TJ, Wakeling A, Huggins R, Zalcberg JR. Hu XF, et al. Among authors: zalcberg jr. Eur J Cancer. 1991;27(6):773-7. doi: 10.1016/0277-5379(91)90187-i. Eur J Cancer. 1991. PMID: 1648945

6

Interaction of cisplatin with other cytotoxics and non-steroidal anti-inflammatory drugs.

Cosolo W, Schwarz MA, Christophidis N, Zalcberg JR. Cosolo W, et al. Among authors: zalcberg jr. Anticancer Drugs. 1991 Apr;2(2):169-74. doi: 10.1097/00001813-199104000-00007. Anticancer Drugs. 1991. PMID: 1958861

7

Rapid functional assay for multidrug resistance in human tumor cell lines using the fluorescent indicator fluo-3.

Wall DM, Hu XF, Zalcberg JR, Parkin JD. Wall DM, et al. Among authors: zalcberg jr. J Natl Cancer Inst. 1991 Feb 6;83(3):206-7. doi: 10.1093/jnci/83.3.206. J Natl Cancer Inst. 1991. PMID: 1988706 No abstract available.

8

Effect of cyclosporin and verapamil on the cellular kinetics of daunorubicin.

Hu XF, de Luise M, Martin TJ, Zalcberg JR. Hu XF, et al. Among authors: zalcberg jr. Eur J Cancer. 1990;26(7):814-7. doi: 10.1016/0277-5379(90)90159-q. Eur J Cancer. 1990. PMID: 2145901

9

Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines.

Hu XF, Martin TJ, Bell DR, de Luise M, Zalcberg JR. Hu XF, et al. Among authors: zalcberg jr. Cancer Res. 1990 May 15;50(10):2953-7. Cancer Res. 1990. PMID: 2334897

10

Heterogeneity of the human transferrin receptor and use of anti-transferrin receptor antibodies to detect tumours in vivo.

Panaccio M, Zalcberg JR, Thompson CH, Leyden MJ, Sullivan JR, Lichtenstein M, McKenzie IF. Panaccio M, et al. Among authors: zalcberg jr. Immunol Cell Biol. 1987 Dec;65 ( Pt 6):461-72. doi: 10.1038/icb.1987.55. Immunol Cell Biol. 1987. PMID: 2452131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results